Announcing our ambitious long-term environmental goals
Our new 2030 goals are part of a renewed Environmental, Social and Governance (ESG) strategy at the world’s leading generic medicine provider.
Biosimilars are advancing more treatment options for patients
Cory Wohlbach is responsible for steering Teva’s new biosimilar products through the regulatory approval process. He explains why biosimilars have the potential to reduce costs for patients, and how patient safety is always a top priority.
Take a closer look at Teva
Environmental, Social and Governance (ESG)
Half the world’s people lack access to medicines
Teva’s ESG team is helping increasing access to our medicines for some of the world’s poorest people. Giancarlo Francese shares how the sheer scale of essential medicines produced by Teva means that we can make a real difference.
Careers at Teva
Dynamic. Diverse. Dedicated. Be Part of the Teva Team
At Teva, we strive to make a difference in the lives of people around the world each and every day.